Quironsalud Madrid
| Turkey | Austria | Spain | |
| Chemotherapy for uterine cancer | from $1,500 | - | from $1,143 |
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Chemotherapy
Day 4 - Post-Treatment
Weeks 1-6 - Rehabilitation
Please note that each patient"s experience with Chemotherapy varies. Always follow your healthcare provider"s advice.
Dr. Luis Madero is the Head of Pediatric Hemato-Oncology at Quironsalud Madrid University Hospital. He specializes in treating complex blood disorders and performing bone marrow transplants. Dr. Madero serves as a Professor of Pediatrics at the Autonomous University of Madrid. He works at Quironsalud Madrid, which Newsweek ranked among the World's Best Hospitals.
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy
Dr. Joan Albanell Mestres is a leading oncologist at Hospital HM Nou Delfos in Barcelona. He heads the breast cancer program at HM Delfos. Dr. Albanell Mestres also directs oncology services at Mar Health Park. He conducted oncology research on telomerase in New York. His work is cited more than 9,000 times in medical literature.
Dr. Agusti Barnadas Molins is the chief breast cancer specialist at Teknon Oncology Institute in Barcelona. He has directed more than 70 research projects on breast cancer and gynecological oncology. Dr. Barnadas Molins treats tumors using chemotherapy, gland therapy, and immunotherapy. He practices at JCI-accredited Centro Médico Teknon.
In Spain, medical oncologists (Oncologia Medica) prescribe and supervise chemotherapy within hospital settings like Oncology Day Hospitals. Specially trained oncology nurses physicalize the administration, while hematologists manage blood-related cancers. These teams collaborate in JCI-accredited centers in Madrid and Barcelona to ensure protocol safety.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra utilize a multidisciplinary approach where medical oncologists strictly coordinate with oncologic surgeons. Data shows these specialists often delay chemotherapy until full physical healing from surgery is confirmed. This protocol helps maintain success rates by ensuring the body can handle systemic treatment.
Patient Consensus: Patients note that care is highly collaborative, with regular follow-ups alternating between surgeons and radiologists. Expect a brief waiting period after surgery for the body to recover before specialists begin the infusion cycles.
Common chemotherapy drugs for endometrial cancer include carboplatin and paclitaxel, which serve as the standard first-line regimen. Spanish oncology centers also utilize cisplatin, doxorubicin, and docetaxel, often combining them with targeted therapies or immunotherapy like pembrolizumab to improve patient outcomes and survival rates.
Bookimed Expert Insight: Spain’s top-tier hospitals like Centro Médico Teknon and Clinica Universidad de Navarra integrate chemotherapy with molecular profiling. This allows doctors to match treatments like PARP inhibitors or Enhertu to your specific tumor markers. Since these facilities are JCI-accredited and ranked by Newsweek, they often provide access to clinical trials not available elsewhere.
Patient Consensus: Patients emphasize the importance of discussing pre-medication options to manage the side effects of the standard carboplatin-paclitaxel combo during their cycles.
Spanish oncology centers frequently combine chemotherapy with surgery, radiotherapy, and immunotherapy to treat uterine cancer. Multimodal protocols, including concurrent chemoradiation and platinum-based chemotherapy after surgery, are standard practices in JCI-accredited facilities like Centro Médico Teknon to improve tumor reduction and long-term success rates.
Bookimed Expert Insight: Spain’s oncology infrastructure offers a high density of specialized technology. Clinics like Hospital Ruber Internacional integrate chemotherapy with advanced Da Vinci Xi robotic systems and Gamma Knife tech. This allows patients to access complex, multimodal treatments in a single facility. High patient volumes, such as 140,000 annually at Navarra Hospital, correlate with deep expertise in managing these combination protocols.
Patient Consensus: Patients should expect a multi-modal plan rather than a single treatment method. Many suggest verifying clinical trial availability early as these often provide access to emerging drug combinations.
Patients typically stay in Spain for 1 day per chemotherapy cycle rather than staying continuously. A full treatment course for uterine cancer spans 3 to 6 months, with sessions scheduled weekly or every 21 days depending on your specific oncology protocol.
Bookimed Expert Insight: Spain offers a unique advantage for international patients through clinical trials. Facilities like Quironsalud Madrid sometimes provide experimental therapies that include full coverage for patient travel costs. This can significantly offset the logistics of multiple trips during a 6-month treatment window.
Patient Consensus: Many patients appreciate the flexibility to vacation between sessions. However, you must ensure you are fully healed from surgeries like a hysterectomy before starting your first cycle.
International patients arrange uterine cancer treatment in Spain by submitting medical records for review at JCI-accredited centers in Barcelona or Madrid. Specialized international departments coordinate multidisciplinary tumor boards, providing access to advanced therapies including robotic surgery and targeted chemotherapy for approximately _price_percent_discount_% less than US averages.
Bookimed Expert Insight: While major centers in Madrid and Barcelona are popular, Clinica Universidad de Navarra in Pamplona serves 140,000 patients annually. Its European Society for Medical Oncology accreditation makes it a high-volume leader for complex cases. Large networks like HM Hospitals provide continuity across their expansive infrastructure for long-term chemotherapy cycles.
Patient Consensus: Patients recommend bringing a Spanish-speaking companion for complex medical discussions. They also advise completing genetic testing before travel to confirm drug suitability and medical necessity.